In Brief: P&G grants to National Women's Health Network

P&G grants to National Women's Health Network: NWHN Executive Director Cindy Pearson discloses two grants of less than 3% of the group's total funding during FDA's Endocrinologic & Metabolic Drugs Advisory Committee review of Merck's alendronate. "To Procter & Gamble's credit, the two grants were both made after we had testified against etidronate," Pearson said. P&G gave the advocacy group $7,500 in 1995 and $15,000 in 1996. NWHN appeared at the meeting to suggest that the committee look carefully at the effect of extending the Fosamax patient population on advertising for the product...